Destiny Pharma. Share Price (DEST)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Destiny Pharma.	LSE:DEST	London	Ordinary Share	GB00BDHSP575	ORD GBP0.01

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	+0.00p	+0.00%	98.40p	0	08:00:00

Bid Price		Offer Price	High Price	Low Price	Open Price
96.80p		100.00p	98.40p	98.40p	98.40p

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Pharmaceuticals & Biotechnology		-3.21	-8.40		42.9

Related Shares
GlaxoSmithKline (GSK), AstraZeneca (AZN), Geiger Count. S (GCS), Port Erin (PEBI)

Destiny Pharma. (DEST) Latest News

Destiny Pharma. News

Date	Time	Source	Headline
26/7/2018	13:49	ALNC	Destiny Pharma Receives Positive Results From Skin Irritation Study
26/7/2018	08:02	ALNCF	Alliance News Flash Headline
26/7/2018	07:01	UKREG	Destiny Pharma PLC Positive Phase 1 skin irritation study with XF-73
17/7/2018	10:42	ALNC	Destiny Pharma Teams With University To Examine XF-Platform Compounds
17/7/2018	07:00	UKREG	Destiny Pharma PLC Research collaboration with Aston University
11/7/2018	07:00	UKREG	Destiny Pharma PLC Notice of Results
21/6/2018	10:25	ALNC	Destiny Pharma Appoints SEHTA Chairman Nick Rodgers As Non-Executive
21/6/2018	07:00	UKREG	Destiny Pharma PLC Directorate Change
14/6/2018	07:00	RNSNON	Destiny Pharma PLC Destiny Pharma notes FDA statement on AMR focus
05/6/2018	14:52	ALNC	DIRECTOR DEALINGS: Destiny Pharma Chairman Rudd And Wife Buy Shares

More Destiny Pharma. News

Destiny Pharma. Takeover Rumours

Destiny Pharma. (DEST) Share Charts

Intraday Destiny Pharma. Chart

Destiny Pharma. (DEST) Discussions and Chat

Destiny Pharma. Forums and Chat

Date	Time	Title	Posts
13/8/2018	13:26	Destiny Pharma plc	28

Add a New Thread

Destiny Pharma. (DEST) Most Recent Trades

No Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type

View all Destiny Pharma. trades in real-time

Destiny Pharma. (DEST) Top Chat Posts

Date	Subject
17/8/2018 09:20	Destiny Pharma. Daily Update: Destiny Pharma. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker DEST. The last closing price for Destiny Pharma. was 98.40p. Destiny Pharma. has a 4 week average price of 98.40p and a 12 week average price of 98.40p. The 1 year high share price is 254.50p while the 1 year low share price is currently 98.40p. There are currently 43,562,598 shares in issue and the average daily traded volume is 3,200 shares. The market capitalisation of Destiny Pharma. is £42,865,596.43. Read Full Thread Reply
02/10/2017 14:47	jonwig: At the risk of being a boor, I'll repeat my post #7 from four weeks ago: I saw the initial RNS and looked at the website. Basically their compounds appear to act so quickly that bacteria have no time to develop resistance via mutation. My immediate reaction to this was extreme scepticism. It appears to suggest that antibiotic resistant mutations happen when bacteria are stimulated by exposure to an agent. But this isn't the case: they happen purely randomly. Indeed there will already exist resistant strains, and resistant populations will develop and increase by natural selection as happens with current antibiotics. I met a biochemist last week (on holiday) whose discipline is immunology, so not quite the same, and he confirmed that my general understanding was correct. Obviously I need to do more study on this and it would be good to see if the company's research has been peer-reviewed. (A lot of these companies don't allow that.) I know their early trials have been successful, and I may be off-beam here, but I wouldn't want to invest in anything I didn't understand. I just can't find any corroborative information about their compounds (Help anyone?), and first results should be some time away. (How much?) Until then, it's unlikely the share price will do more than respond to speculative froth. A trigger will be phase results, and it's unlikely these can leak as they should be double-blind and reported immediately. When they are, how many here will understand them? More to the point, they seem to have £14m cash with a burn of £2m pa (but that will increase). At least they won't have to scramble. Read Full Thread Follow Reply

Date

Subject

17/8/2018
09:20

Destiny Pharma. Daily Update: Destiny Pharma. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker DEST. The last closing price for Destiny Pharma. was 98.40p.
Destiny Pharma. has a 4 week average price of 98.40p and a 12 week average price of 98.40p.
The 1 year high share price is 254.50p while the 1 year low share price is currently 98.40p.
There are currently 43,562,598 shares in issue and the average daily traded volume is 3,200 shares. The market capitalisation of Destiny Pharma. is £42,865,596.43.

Read Full Thread

02/10/2017
14:47

jonwig: At the risk of being a boor, I'll repeat my post #7 from four weeks ago: I saw the initial RNS and looked at the website. Basically their compounds appear to act so quickly that bacteria have no time to develop resistance via mutation. My immediate reaction to this was extreme scepticism. It appears to suggest that antibiotic resistant mutations happen when bacteria are stimulated by exposure to an agent. But this isn't the case: they happen purely randomly. Indeed there will already exist resistant strains, and resistant populations will develop and increase by natural selection as happens with current antibiotics. I met a biochemist last week (on holiday) whose discipline is immunology, so not quite the same, and he confirmed that my general understanding was correct. Obviously I need to do more study on this and it would be good to see if the company's research has been peer-reviewed. (A lot of these companies don't allow that.) I know their early trials have been successful, and I may be off-beam here, but I wouldn't want to invest in anything I didn't understand. I just can't find any corroborative information about their compounds (Help anyone?), and first results should be some time away. (How much?) Until then, it's unlikely the share price will do more than respond to speculative froth. A trigger will be phase results, and it's unlikely these can leak as they should be double-blind and reported immediately. When they are, how many here will understand them? More to the point, they seem to have £14m cash with a burn of £2m pa (but that will increase). At least they won't have to scramble.

Read Full Thread

Destiny Pharma. share price data is direct from the London Stock Exchange

add chat code

Your Recent History

LSE

GKP

Gulf Keyst..

LSE

QPP

Quindell

FTSE

UKX

FTSE 100

LSE

IOF

Iofina

GBPUSD

UK Sterlin..

Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US Finance Manila

P:43 V: D:20180817 18:48:41